Vaccinia virus B18R, recombinant (C-6His)

Vaccinia virus B18R, recombinant (C-6His)
Item number Size Datasheet Manual SDS Delivery time Quantity Price
NOV-CM32.10ug 10 µg - -

10 - 15 business days*

150.00€
NOV-CM32.50ug 50 µg - -

10 - 15 business days*

440.00€
NOV-CM32.500ug 500 µg - -

10 - 15 business days*

1,540.00€
NOV-CM32.1mg 1 mg - -

10 - 15 business days*

2,200.00€
 
Recombinant Vaccinia virus Soluble Interferon Alpha/beta Receptor B18 is produced by our... more
Product information "Vaccinia virus B18R, recombinant (C-6His)"
Recombinant Vaccinia virus Soluble Interferon Alpha/beta Receptor B18 is produced by our Mammalian expression system and the target gene encoding His20-Glu351 is expressed with a 6His tag at the C-terminus. Protein function: Counteracts the antiviral effects of host IFN-alpha/beta. Acts as a soluble IFN-alpha receptor and thus inhibits the interaction between host IFN-alpha and its receptor. [The UniProt Consortium]
Keywords: B18, B18R, VACWR200, Soluble interferon alpha/beta receptor B18, Recombinant Vaccinia virus B18R (C-6His)
Supplier: Novoprotein
Supplier-Nr: CM32

Properties

Conjugate: No
Host: Human cells
Species reactivity: Vaccinia virus
MW: 39.2 kD
Format: Lyophilized

Database Information

UniProt ID : P25213 | Matching products

Handling & Safety

Storage: -20°C (+4 °C for short term storage)
Shipping: +20°C (International: +20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Vaccinia virus B18R, recombinant (C-6His)"
Write a review
or to review a product.
Viewed